Clinical Trial Update: P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating drug–drug interaction, multiple-ascending-dose pharmacokinetics, and safety of Xeruborbactam oral prodrug in combination with ceftibute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Xeruborbactam oral prodrug (Xeruborbactam)
• ceftibuten (ceftibuten)

Snippet

Sponsor: Qpex Biopharma, Inc. | Conditions: Bacterial Infections | Phase 1 | Status: COMPLETED